Noor Siddiqui, founder and CEO of Orchid, during the web summit for careers during Day 2 of the 2014 Web Summit in Dublin, Ireland, Nov. 5, 2014.
Stephen McCarthy | Getty Images
Reproductive technology startup Orchid on Tuesday announced a comprehensive new genetic test that may help many prospective parents across the U.S. breathe a little easier.
The company is launching the first commercially available whole genome sequencing report for embryos, designed for couples undergoing in vitro fertilization, which is a type of treatment for people experiencing infertility or who are at risk of passing on genetic problems.
With IVF, after a woman has had around two weeks of daily hormone injections, her mature eggs are extracted and fertilized in a lab, and the viable embryos are later transferred into the uterus.
Orchid said its new test will help couples identify whether their embryos present genetic risks such as birth defects, neurodevelopmental disorders, chromosomal abnormalities, or pediatric and adult-onset cancers that were previously only detectable after birth.
“This is a major advance in the amount of information parents can have,” Noor Siddiqui, Orchid’s founder and CEO, told CNBC in an interview. “The way that you can use that information is really up to you, but it gives a lot more control and confidence into a process that, for all of history, has just been totally left to chance.”
Orchid’s technology sequences more than 99% of an embryo’s genome, while existing tests typically read around .25%, the company said in a release.
IVF is a taxing process that can cost an average of more than $12,000 in the U.S., according to the Institute for Reproductive Health. Success is not guaranteed, and some people go through multiple rounds of IVF before a pregnancy develops.
Orchid’s genetic test will cost couples an additional $2,500 per embryo sequenced, but it does not add any new steps or risks to the IVF process, Siddiqui said. She added that the cost of the report should come down as the company is able to scale up its operations and introduce more automation.
“We want to make this something that’s accessible to everyone,” Siddiqui said.
Beginning Tuesday, Orchid’s technology will be available at IVF clinics in major cities such as Los Angeles, Chicago, Miami and Austin, and Siddiqui said Orchid can be made available at additional clinics at the request of patients.
Couples will receive their report back from Orchid after about three weeks, the company said, and a board-certified genetic counselor will help them understand the results.
Orchid’s whole genome embryo report
Courtesy: Orchid
Orchid has secured $12 million in funding from investors such as Prometheus Fund and Refactor Capital. Anne Wojcicki, the co-founder and CEO of 23andMe; Dylan Field, the co-founder and CEO of Figma; Fidji Simo, the CEO of Instacart; Brian Armstrong, the co-founder CEO of Coinbase, and others are also backers.
For many hopeful parents, the peace of mind is worth Orchid’s steep price.
Roshan George, a 35-year-old engineer in San Francisco, began the IVF process with his wife, Julie, in the fall.
George said they were feeling some anxiety about having a baby at an older age, and their nerves were amplified after their IVF clinic discovered they are both carriers for nonsyndromic hearing loss, which can result in a partial or total loss of hearing.
George had heard of Orchid through some friends, he said, and the couple decided to sequence all three of their viable embryos with the company. He said getting the embryos tested was very straightforward, and when the results came back, they discovered that two out of the three embryos were healthy.
“We were super relieved right off the bat,” George told CNBC in an interview. “That was very gratifying to hear.”
“Just having some degree of certainty — you’re going to make sure they’re not sick when they’re born and all that sort of stuff — it’s a huge amount of anxiety that’s been lifted off,” George said.
George Church, a professor of genetics at Harvard Medical School, is an investor and an adviser at Orchid. Church developed the first direct genome sequencing method, he said, and Orchid’s technology will give parents the ability to access a hundred times more information about their baby than they could attain previously.
Church said it is “perfectly logical” for parents to care about helping their children, whether it pertains to their genetic health, the quality of their food or whether they get enough sleep and exercise.
He added that people often think that genetic risks don’t apply to them, or that there’s nothing they can do if something is wrong. But with Orchid, Church said parents have the detailed information they need to make informed decisions.
“If you went to Las Vegas with a 97% chance of winning, you would definitely go to Las Vegas,” Church told CNBC in an interview. “But it’s different when you’re talking about quarters as opposed to children.”
Orchid’s primary focus after the launch Tuesday will be on scaling up its technology and making it more accessible, Siddiqui said.
She said Orchid has spent an “enormous amount of effort” identifying the mutations that will cause severe disease during pregnancy or early childhood or result in serious chronic conditions. She wanted to ensure the company is able to provide parents with information that is “super meaningful.”
“I think this has the potential to totally redefine reproduction,” Siddiqui said. “I just think that’s really exciting to be able to make people more confident about one of the most important decisions of their life, and to give them a little bit more control.”
SpaceX CEO Elon Musk attends a cabinet meeting held by U.S. President Donald Trump at the White House on March 24, 2025.
Win McNamee | Getty Images
Tesla shares fell almost 6% on Monday, a day ahead of the electric vehicle company’s first-quarter earnings report, as analysts fret over “ongoing brand erosion.”
The stock closed at $227.50 leaving it less than $6 above its low for the year on April 8. The shares are now down 44% for the year after wrapping up their worst quarter since 2022 in March. It’s the 12th time this year the stock has dropped by at least 5% in a single session.
CEO Elon Musk’s many distractions outside of Tesla, especially his role within the Trump administration, are in focus, along with the company’s progress on a long-delayed robotaxi and self-driving technology for its existing cars.
In the online forum that Tesla uses to solicit investor inquiries in advance of its earnings calls, more than 300 questions were submitted pertaining to Tesla’s self-driving systems, around 200 came in about the company’s Optimus humanoid robots in development, and more than 160 questions poured in about Musk individually. One investor asked, “What steps has the board of directors taken to mitigate the brand damage caused by Elon’s political activities?”
After spending $290 million to help return Trump to the White House, Musk is now leading an initiative to slash tens of thousands of federal jobs, sell off or end leases for federal office buildings, and reduce U.S. government capacity.
Musk’s politics and antics have elicited a massive backlash in Europe and parts of the U.S. This year, the company has been hit with waves of protests, boycotts and some criminal activity that targeted Tesla vehicles and facilities in response to Musk.
Earlier this month, Tesla reported 336,681 vehicle deliveries in the first quarter, a 13% decline from the same period a year earlier.
The company is expected to report revenue of $21.24 billion for the first quarter, according to LSEG, which would mark a slight drop from the same period last year. Analysts expect earnings per share of 40 cents. Investors will be paying particularly close attention to any commentary about Trump’s widespread tariffs and the potential impact on revenue and earnings as the year progresses.
Oppenheimer analysts wrote in a note out Monday that “ongoing brand erosion” for Tesla in the U.S. and Europe is weighing on sales already, but a “bigger issue for the company is potential weakness in China demand and margin impact due to the Trump tariffs.”
They wrote that competition in China, coupled with “nationalistic” consumer trends there, could “drive sales toward domestic brands.” Tesla would then have to export more of its China-made cars, which could lead to “downward pressure on pricing,” the Oppenheimer analysts said.
Caliber, a research firm that tracks how U.S. consumer sentiment is shifting around major brands, found that only 27% of its survey respondents in March would consider purchasing a Tesla, compared to 46% in January 2022.
Wedbush Securities analyst Dan Ives, a longtime Tesla bull, is hoping for a “turnaround vision” from Musk on Tuesday’s earnings call.
“Tesla has now unfortunately become a political symbol globally of the Trump Administration/DOGE,” he wrote, noting that “Tesla’s stock has been crushed since Trump stepped back into the White House.”
Ives estimated 15% to 20% “permanent demand destruction for future Tesla buyers due to the brand damage Musk has created” by working for Trump.
Late last week, Barclays maintained the equivalent of a sell rating and slashed its price target on Tesla to $275 from $325, citing a “confusing set-up” on the first-quarter with “weak fundamentals.” The firm said it could see a positive reaction if Musk is more focused on his automaker, and depending on what the company discloses about an anticipated “FSD event,” referring to Tesla’s Full Self-Driving offering.
Tesla said in announcing its reporting date that, in addition to earnings, it will provide a “live company update,” language the company hasn’t typically used in disclosures.
CEO of Alphabet and Google Sundar Pichai meets Polish Prime Minister at the Chancellery in Warsaw, Poland on March 29, 2022.
Mateusz Wlodarczyk | Nurphoto | Getty Images
As Google heads back to the courtroom Monday, the company is arguing that the U.S. needs the company in its full form to take on chief adversary China and uphold national security in the process.
The remedies trial in Washington, D.C., follows a judge’s ruling in August that Google has held a monopoly in its core market of internet search, the most-significant antitrust ruling in the tech industry since the case against Microsoftmore than 20 years ago.
The Justice Department has called for Google to divest its Chrome browser unit and open its search data to rivals. Google said in a blog post on Monday that such a move is not in the best interest of the country as the global battle for supremacy in artificial intelligence rapidly intensifies. In the first paragraph of the post, Google named China’s DeepSeek as an emerging AI competitor.
The DOJ’s proposal would “hamstring how we develop AI, and have a government-appointed committee regulate the design and development of our products,” Lee-Anne Mulholland, Google’s vice president of regulatory affairs, wrote in the post. “That would hold back American innovation at a critical juncture. We’re in a fiercely competitive global race with China for the next generation of technology leadership, and Google is at the forefront of American companies making scientific and technological breakthroughs.”
Google is one of a number of U.S. tech companies trying to fend off the Trump administration’s antirust pursuits, most of which is held over from the Biden administration. Google lost a separate antitrust case last week, when a federal judge ruled Thursday that Google held illegal monopolies in online advertising markets due to its position between ad buyers and sellers.
Meta is currently in court against the Federal Trade Commission, which has alleged that the company monopolizes the social networking market and shouldn’t have been able to acquire Instagram and WhatsApp. Amazon also faces an FTC lawsuit for allegedly maintaining an illegal monopoly. And beyond antitrust, Trump’s FTC on Monday sued Uber, accusing the ride-hailing company of deceptive billing and cancellation practices tied to its subscription service.
It’s the type of enforcement actions the tech industry was hoping to avoid when President Trump took office in January. Google, Meta, Amazon and Uber — and top executives from some — publicly donated to Trump’s inaugural fund, part of a widespread corporate effort to cozy up to the incoming administration.
For Google, the search remedies trial will determine the consequences of the guilty verdict from August. The three-week trial will end on May 9. Judge Amit Mehta is expected to make his ruling in August, at which point Google plans to file an appeal.
“At trial we will show how DOJ’s unprecedented proposals go miles beyond the Court’s decision, and would hurt America’s consumers, economy, and technological leadership,” Mulholland wrote.
Google plans to argue that Chrome provides freedom. The browser helps people access the web, and its open source code is used by other companies. One of the DOJ’s proposals is that Google open its search data, such as search queries, clicks and results to other companies.
That would “introduce not just cybersecurity and even national security risks, but also increase the cost of your devices,” Google said.
A central part of Google”s challenge is to strike a balance between being seen as essential to American innovation, but not so essential that other companies can’t compete, particularly when it comes to AI.
Google will likely tout how it’s fueled AI innovation for years and will point to the “Transformers” research paper, which provided technical architecture used in AI chatbots like OpenAI’s ChatGPT, Perplexity and Anthropic.
The DOJ has said that in search, “Google’s agreements continue to insulate Google’s monopoly.” The department plans to bring testimony from Nick Turley, ChatGPT’s head of product, and Perplexity Chief Business Officer Dmitry Shevelenko.
In a blog post on Monday, Perplexity said that “the remedy isn’t breakup,” but rather that consumers should have more choice. The company said phone makers should be able to offer their customers an assortment of search options “without fearing financial penalties or access restrictions.”
“Consumers deserve the best products, not just the ones that pay the most for placement,” Perplexity wrote. “This is the only remedy that ensures consumer choice can determine the winners.”
Amazon CEO Andy Jassy speaks at a company event in New York on Feb. 26, 2025.
Michael Nagle | Bloomberg | Getty Images
Amazon has delayed some commitments around new data center leases, Wells Fargo analysts said Monday, the latest sign that economic concerns may be affecting tech companies’ spending plans.
A week ago, a Microsoft executive said the software company was slowing down or temporarily holding off on advancing early build-outs. Amazon Web Services and Microsoft are the leading providers of cloud infrastructure, and both have ramped up their capital expenditures in recent quarters to meet the demands of the generative artificial intelligence boom.
“Over the weekend, we heard from several industry sources that AWS has paused a portion of its leasing discussions on the colocation side (particularly international ones),” Wells Fargo analysts wrote in a note. They added that “the positioning is similar to what we’ve heard recently from MSFT,” in that both companies are reeling in some new projects but not canceling signed deals.
Tech stocks have been under pressure across the board his year as President Donald Trump’s proposals for widespread tariffs raised the prospect for dramatically higher costs on imports of equipment while also threatening to slow the economy. Cloud infrastructure providers have been aggressively announcing plans to collectively spend hundreds of billions of dollars securing Nvidia’s graphics processing units, or GPUs, and building new data centers.
That was before the announcement on tariffs earlier this month. Microsoft and Amazon both report quarterly results next week. Their stock prices were down on Monday, bringing Amazon’s decline for the year to 25% and Microsoft’s drop to 15%.
An AWS spokesperson did not immediately provide a comment. Earlier this month, Amazon CEO Andy Jassy told CNBC’s Andrew Ross Sorkin that he did not see the company cutting down on data center construction.